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Introduction
Between 2006-2011, the number of people diag-
nosed with diabetes mellitus (DM) has increased
by 25% in the UK alone, from 1.9 million to 2.5
million (1). Furthermore, the number of people
with undiagnosed DM is estimated to be around
850,000. Based on the existing trends, the num-
ber of diabetics in the UK is expected to reach 5
million by 2025. Type 2 DM is more prevalent
(90%) than type 1 DM (10%) (2). Concomitantly,
DM-related complications like amputations,
stroke, blindness, and end-stage kidney failure
are also on the rise and are life threatening with
a high mortality rate. Schofield et al. (3) reported
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Lower limb amputation is a major procedure performed in
diabetic patients with multiple comorbidities. Almost 10%
of the National Health Service budget is taken up by dia-
betes, with diabetes-related complications accounting for
80% of the costs. The process of wound healing is com-
plex and involves regenerating the cellular organization
and the tissue layers. Diabetics are five times more pre-
disposed to wound infection than patients without diabe-
tes mellitus. The amputated stump frequently becomes
infected due to inadequate blood circulation, a weak im-
mune system, and poorly controlled diabetes mellitus.
Pain, stump edema, and osteomyelitis are significant com-
plications associated with lower limb amputation wounds.
A number of factors may substantiate the need for re-am-
putation, such as stump pain and/or phantom limb pain,
delayed stump infection, the formation of symptomatic
bone spurs, assessment of the skin flap designed to pre-
serve stump length, and preparation of the stump for the
prosthetic device. There are currently no reliable stan-
dards that can be referred to prior to leg amputation. The
clinicians, therefore, have to rely on their judgment and
investigatory parameters. The main purpose of this review
is to discuss the difficulties of stump healing in the diabe-
tic population.
Keywords: Diabetes; complication; leg amputation;
stump healing
Alt ekstremite ampütasyonu, eşlik eden birden fazla hasta-
lığı olan diyabetik hastalarda yapılan önemli bir işlemdir. Ulu-
sal sağlık hizmetleri) bütçesinin hemen hemen %10’u
diyabet tarafından kullanılmakta olup, bu maliyetin
%80’inden diyabete bağlı komplikasyonlar sorumludur. Yara
iyileşmesi karmaşık bir süreçtir ve hücresel organizasyon ve
doku tabakalarının yeniden oluşumunu kapsamaktadır. Di-
yabetik hastalar, diabetes mellitusu olmayan hastalara kı-
yasla yara enfeksiyonuna beş kat daha fazla yatkındır.
Ampütasyon güdüğü ise, yetersiz kan dolaşımı, zayıf bir ba-
ğışıklık sistemi ve kontrol altına alınamamış diabetes melli-
tus nedeni ile sıklıkla enfekte olmaktadır. Ağrı, güdük ödemi
ve osteomiyelit alt ekstremite ampütasyon yaraları ile ilişkili
en önemli komplikasyonlardır. Güdük ağrısı ve/veya hayalet
ekstremite ağrısı, geç güdük enfeksiyonu, semptomatik
kemik mahmuzu oluşumu, güdük uzunluğunu korumak için
tasarlanan deri flebinin değerlendirilmesi ve güdüğün protez
için hazırlanması gibi faktörler yeniden ampütasyon yapıl-
ması için ihtiyaç yaratabilmektedir. Günümüzde, bacak am-
pütasyonu öncesi başvurulacak güvenilir standartlar
bulunmamaktadır. Bu nedenle klinisyenler, kendi yargılarına
ve incelenen parametrelere güvenmek durumundadır. Bu ça-
lışmada, diyabetik populasyonda güdük yarası iyileşmesinin
komplikasyonlarının tartışılması amaçlanmıştır.
Anahtar kelimeler: Diyabet; komplikasyon;
bacak ampütasyonu; güdük iyileşmesi
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that the median time to death following lower
limb amputation was higher in patients with DM
than in healthy controls (27.2 months vs. 46.7
months, p=0.01). In addition, the study also
found that patients with DM had a higher risk of
developing congestive heart disease or needing
an amputation by factors of 2.26 (95% CI 1.12-
4.5) and 1.95 (95% CI 1.14-3.33), respectively.
Diabetic foot disease often leads to serious long-
term complications, resulting in significant socio-
economic and healthcare burdens. The UK
National Health Service (NHS) is under enormous
financial strain as a result of diabetic foot com-
plications, which is reflected in greater outpatient
costs, bed occupancy, and extended hospitaliza-
tion. The cost of diabetic foot care to the NHS
during 2010-2011 was £639-662 million.
The ability and the time required for a patient to
walk with a prosthetic limb after a lower limb am-
putation is determined largely by the process of
wound healing (4). In addition, the type of treat-
ment wound characteristics and the condition of
the patient also affect the stump healing process.
Pino et al. (5) reviewed 19 studies on lower limb
amputation in patients with DM and concluded
that a complete preoperative workup is desirable
before an amputation with emphasis on the prob-
able rate of healing, the functional condition of
the limb prior to surgery, control or treatment of
any additional diseases, and selection of the level
of amputation based on latest techniques. The
main purpose of this study was to discuss the
problem of stump healing in the diabetic popula-
tion.
Types of Healing
Amputations are considered to have healed pri-
marily if the wound healed without additional de-
bridement or revision. Longer wound healing that
prevents prosthetic fitting for at least three
months, but eventually leads to closure of the
wound is classified as “delayed.” When amputa-
tions are complicated by wound necrosis or se-
vere infection, leading to repeated surgery, the
wound healing is classified as “failed” (6). The
process of wound healing is complex and entails
regenerating the cellular organization and the tis-
sue layers. Mercandetti et al. (6) have classified
the wound healing process into three categories:
1) category 1 healing, also known as primary
wound healing or healing by the first intention,
results in minimum damage to cellular struc-
tures, 2) category 2 or delayed primary wound
healing occurs when the margins of the wound
are not reconfigured promptly and may prove
beneficial if the wound becomes infected, and 3)
category 3 or secondary healing allows a full-
thickness wound to close and heal on account of
extensive inflammation which stimulates the
wound to recede.
Complications of Stump Healing
Lower limb amputation surgery is frequently per-
formed in patients who have multiple comorbidi-
ties. A large number of patients with DM are
hospitalized due to lower limb-related problems
(7) such as infection, pain, and osteomyelitis
(Figure 1). McIntosh et al. (8) carried out a ret-
rospective study from 2005 to 2007 on 231 pa-
tients who underwent major amputations of
lower extremities. They observed that 7.3% of
the patients experienced wound infection, phan-
tom pain, poor body image, depression and my-
ocardial infarction following the amputations.
Diabetics are twice more likely to experience con-
gestive cardiac failure and deep vein thrombosis
(DVT; 11% risk) after amputation than patients
without DM (3).
Infection of the Stump
Patients who have undergone amputation can de-
velop severe problems as a result of infections,
especially if they suffer from DM. The amputated
stump frequently becomes infected requiring re-
amputation (9). The wound infection rates fol-
lowing major lower limb amputation vary
between 13% and 40%. Methicillin-resistant
Staphylococcus aureus (MRSA) is the most com-
mon cause of post-amputation infections (10,
11). The morbidity and mortality rates usually in-
Figure 1: Major complications of stump healing.
crease as a result of MRSA infection in vascular
patients (12-14).
As indicated by Ray (15), patients with DM are
five times more predisposed to wound infections
than patients without DM, and the presence of
peripheral vascular disease further increases the
risk of infection. In a study by Aulivola et al. (16),
an infection develops in 5.5% of trans-tibial and
6.7% of trans-femoral amputations. A wound in-
fection can produce excessive amounts of dis-
charge that disrupt the suture line (17), and
Baxter (18) showed that an extensive infection
can even cause wound rupture and tissue death,
thus requiring additional surgical interventions.
According to the Infection Surveillance Service in
England (2006), leg amputations are associated
with the highest risk of infection since a large
number of patients are subjected to this proce-
dure as a consequence of severely infected ul-
cerations. Additionally, a number of factors such
as inadequate blood circulation, a weak immune
system, and poorly controlled DM may increase
the likelihood of infection.
As noted by Grey (19), cellulitis is another prob-
lem which can accompany leg amputation and
manifests as inflammation, pain, pus formation,
redness, heat, and pyrexia. Serious cases of cel-
lulitis progress to septicemia. The use of prophy-
lactic antibiotics has reduced the incidences of
wound infection and cellulitis, resulting in a de-
cline in not only the rate of infection but also in
the rate of re-amputation (8). Therefore, it is cru-
cial to ensure effective treatment of wound in-
fections to aid the healing process and to
minimize the morbidity and mortality rates.
Pain in the Stump
Pain is a significant and complex problem ac-
companying lower limb amputation. Incision
stump pain and phantom limb pain are the two
kinds of pain that amputees experience. Stump
pain is limited to the area closely surrounding the
stump and amputation site (20). If left untreated,
it can adversely influence the wound healing
process and consequently, reduce the patient’s
quality of life. Opiates and non-steroidal anti-in-
flammatory agents have been shown to alleviate
stump pain. According to Chan et al. (21), 90%
of amputees experience phantom limb pain,
which has been described as a crushing, tearing
pain which the patients feel in the amputated
limb (22). Phantom limb pain occurs after ampu-
tation and can endure for a few years or, in rare
cases, for the rest of a patient’s life (20).
Tissue Necrosis of the Stump
As a large number of amputations are performed
due to ischemia, inadequate circulation in the
stump area can cause tissue necrosis, which
manifests as changes in skin color, dry gangrene,
or wet gangrene. Ray (15) pointed out that
changes in skin color around the incision line can
indicate wound rupture following surgical inter-
vention, or even tissue death a number of weeks
after the procedure.
Debridement is a frequently used technique to
accelerate wound healing (23). Low amounts of
dead tissue are usually left to the natural process
of autolysis, once it is ascertained that they are
harmless. In cases of significant necrosis, how-
ever, wound debridement is preferred. The deci-
sion as to the optimum method for dead tissue
removal (24) depends on a number of factors
such as convenience, wound type, location, and
costs (25). Larval therapy, which uses sterile
maggots, is a frequently used debridement
method in the UK. The popularity of this method
is attributed to the fact that it is the only viable
option in most cases since the presence of co-
morbidities often prevents surgical intervention
or other methods of stump debridement (26).
Stump Edema
Stump edema is a common problem faced by
amputees, especially those who are suitable for
prosthetic fitting. According to Ray (15), pre-ex-
isting venous deficiency, generalized fluid reten-
tion due to congestive heart failure and chronic
hyper vascularity are some of the factors caus-
ing extensive and protracted edema. Hypervas-
cularity is frequently encountered in DM patients
without a severely disrupted circulation.
Extensive edema and discharge delay the stump
healing process. Scanlon et al. (27) argued that
some components of the wound exudates have a
negative effect on wound healing, as well as on
the surrounding skin. The development and in-
fection of seroma/hematoma are considered to
be the causes of exaggerated wound discharge
(15). A number of researchers (28, 29) have rec-
ommended periodically elevating the amputated
leg to limit edema around the stump area. The
appropriate wound dressing is also essential to
maintain a good moisture level within the wound.
Banwell et al. (30) have suggested that topical
negative pressure on discharging stump wounds
can stimulate fluid elimination and thus decrease
the risk of edema (31). In addition, it is vital to
maintaining skin hygiene in patients with edema
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as they are more prone to develop infections or
even cellulitis due to impaired cellular and lym-
phatic functions (32). Edema can be reduced by
wrapping the stump wound in elastic bandages
(33), which protect the healing tissue, keep the
dressings in place, limit inflammation and shape
the remaining limb, thereby preparing it for the
prosthetic device (34).
Limb swelling due to deep vein thrombosis (DVT)
often occurs in patients who have undergone leg
amputation (35). Apart from DVT, limb swelling
can also develop as a result of hypoproteinemia,
stump dependency, and infection. It is crucial to
determine the exact cause of stump edema in
order to prescribe the proper treatment, such as
a high protein diet.
Osteomyelitis
Osteomyelitis is a dreaded complication post am-
putation as it can result in life-threatening sepsis
(36). The bone in the amputation area can be-
come exposed through the skin as a result of mus-
cle withdrawal from the stump (15). A ruptured
wound can facilitate bone exposure, increasing the
risk of osteomyelitis. Surgical intervention is
needed if the area of exposed bone is extensive,
and the granulation tissue cannot cover it through
secondary healing. As noted by Lipsky et al. (37),
the diagnosis and treatment of osteomyelitis in
patients with DM pose considerable difficulties and
requires the early involvement of a multidiscipli-
nary team. Diabetes-related osteomyelitis is diag-
nosed based on clinical, biochemical and
radiological evidence as well as findings of some
bedside test. It is possible to carry out a probe-
to-bone test but its accuracy is doubtful (38, 39).
However, the main method used to diagnose os-
teomyelitis is a microbiological examination of the
bone biopsy (40). After initial radiography, mag-
netic resonance imagining (MRI) is used to assess
the development of pedal osteomyelitis and the
extent of soft tissue infection, with a sensitivity
and specificity of 90% and 83%, respectively (41).
Stump Hematoma
Bale et al (42) defined hematoma as a localized
accumulation of blood inside an organ, cavity or
tissue. A hematoma provides a suitable environ-
ment for the development of infection and can
generate dead space, undermining the suture
line and expanding the level of tension in the
wound (18). Hematomas usually drain freely and
do not necessitate surgery. Nevertheless, surgical
debridement is used to remove considerable
quantities of coagulated blood (15). Morrison et
al. (43) reported an increased likelihood of
hematoma formation under the suture line in the
case of wounds without drainage, which can lead
to the development of tension, edema, and in-
fection. Furthermore, the blood circulation can
also be affected by the increased tension under
the suture line, causing wound rupture and tis-
sue death (44). A hematoma should be identified
using efficient evaluation methods and the pa-
tient must be referred to surgery immediately if
needed.
Wound Dehiscence
Wound dehiscence refers to the sudden opening
of the wound along the suture line and is accom-
panied by a sharp increase in serosanguineous
drainage (45). It usually occurs when the wound
is too weak to resist exterior forces such as shear
or direct trauma (42), as a result of the prema-
ture removal of sutures, or stump edema which
creates tension in the wound. Total dehiscence
can potentially determine the exposure of muscle
and bone (18).
Harker (23) proposed the use of topical negative
pressure on the amputated area to prevent
wound dehiscence, which has had a higher suc-
cess rate in previous applications (46). Topical
negative pressure therapy, such as the vacuum-
assisted closure (VAC) system, can handle ex-
tensive quantities of exudates and safeguard the
skin against maceration and abrasion, thereby
limiting the risk of infection. It also stimulates the
generation of granulation tissue inside the cavity
wound. The main disadvantage of the topical
negative pressure therapy, however, is that many
patients cannot tolerate the pain (47). Studies
that have discussed the complexity of dehisced
amputation wounds and the difficulties in treating
them have recommended the collaboration of dif-
ferent specialists to gain positive results (17).
Non-Healing Requiring
a Higher-Level Amputation
Re-amputation refers to a higher level amputa-
tion secondary to non-healing of the stump.
There are a number of factors which may sub-
stantiate the need for re-amputation, such as
stump pain and/or phantom limb pain, delayed
stump infection, the formation of symptomatic
bone spurs, assessment of the skin flap designed
to preserve stump length, and preparation of the
stump for the prosthetic device. Dillingham et al.
(48) observed that re-amputation is more likely
to be performed in the diabetics than in patients
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without DM. Reiber (49) estimated that 9% to
20% of patients with DM with an initial leg am-
putation undergo re-amputation within the first
year, and 28% to 51% of patients with DM ne-
cessitate re-amputation within five years of the
original amputation.
Death Following an Inability to
Heal Stump
Criqui et al. (50) revealed that the likelihood of
amputees with the peripheral vascular disease to
die as a result of cardiovascular complications
within ten years of the amputation is six times
higher than that of amputees without the periph-
eral vascular disease. Lee et al. (51) reported
that the most common cause of death after a
lower limb amputation was DM (37.3%), cardio-
vascular disease (29.1%), and renal disease
(7.3%). According to Mayfield et al. (52), the
mortality rate among patients with renal disease,
cardiovascular disease or proximal amputation
level was high during the first 12 months of the
procedure. Toursarkissian et al. (53) reported
that the mortality rates increased by 23%, 41%,
and 80% in the period immediately following the
amputation, after one year, and after five years
of the procedure, respectively.
The five-year mortality rates associated with
above-knee and below-knee amputation were es-
timated at 90% and 70%, respectively (54). Ten-
tolouris et al. (55) found that 61% of patients
with DM aged between 67 and 76 years who had
undergone amputation, were likely to die within
five years of the operation. Heikkinen et al. (56)
reported that the post-amputation mortality rate
even among the younger patients with DM was
significantly higher than that of non-diabetics. Ac-
cording to Schofield et al. (3), the mortality rate
among amputees with DM was 55% higher than
among patients without DM. One reason for the
high mortality rate may be the greater emphasis
on rescuing the limb which delays amputation to
only when revascularization is not feasible.
Conclusion
Successful stump healing is a pre-requisite for am-
bulation following a lower limb amputation. This
review has provided a detailed evaluation of the
risks conferred by some of the key complications of
lower limb stump healing. There are currently no
reliable standards that can be referred to prior to
leg amputation surgery. The clinicians, therefore,
have to rely on their own judgment and other in-
vestigatory parameters including a pre-operative
angiogram which has a major role in determining
the level of amputation. In order to identify which
lower limb stumps would heal following a major
lower limb amputation, a pre-surgery prediction
rule needs to be formulated and verified.
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